Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiran Yang

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|August 1, 2016
Cardiac action of the first G protein biased small molecule apelin agonistCai Read, Christopher M Fitzpatrick, Peiran Yang, et al.
The Journal of International Medical Research|June 17, 2026
Plasma soluble triggering receptor expressed on myeloid cells 2 levels and clinical outcomes in acute decompensated heart failure: A retrospective cohort studyJie Li, Mengyu Wang, Jing Ma, et al.
Journal of Patient Safety|September 27, 2021
Evaluation of In-Hospital Venous Thromboembolism Prevention and Management System Using Hospital-Level Metrics: A Nationwide Cross-Sectional Survey in ChinaKaiyuan Zhen, Fen Dong, Fang Fang, et al.
Nature Communications|September 3, 2024
Midlatitude mesoscale thermal Air-sea interaction enhanced by greenhouse warmingXiaohui Ma, Xingzhi Zhang, Lixin Wu, et al.
Thrombosis Journal|February 5, 2024
Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysisShuangshuang Ma, Guohui Fan, Feiya Xu, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 1, 2022
Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment: Developed and Validated from 1,017 Medical and Surgical PatientsZhu Zhang, Yifan Wu, Qingxia Liu, et al.
Frontiers in Cardiovascular Medicine|August 22, 2022
Association between <i>CES1</i> rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysisHaobo Li, Zhu Zhang, Haoyi Weng, et al.
Pharmacological Reviews|March 27, 2026
International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applicationsAnthony P Davenport, Thomas L Williams, Duuamene Nyimanu, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Hypertension (Dallas, Tex. : 1979)|February 26, 2015
Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonistAimee L Brame, Janet J Maguire, Peiran Yang, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|August 1, 2016
Cardiac action of the first G protein biased small molecule apelin agonistCai Read, Christopher M Fitzpatrick, Peiran Yang, et al.
The Journal of International Medical Research|June 17, 2026
Plasma soluble triggering receptor expressed on myeloid cells 2 levels and clinical outcomes in acute decompensated heart failure: A retrospective cohort studyJie Li, Mengyu Wang, Jing Ma, et al.
Journal of Patient Safety|September 27, 2021
Evaluation of In-Hospital Venous Thromboembolism Prevention and Management System Using Hospital-Level Metrics: A Nationwide Cross-Sectional Survey in ChinaKaiyuan Zhen, Fen Dong, Fang Fang, et al.
Nature Communications|September 3, 2024
Midlatitude mesoscale thermal Air-sea interaction enhanced by greenhouse warmingXiaohui Ma, Xingzhi Zhang, Lixin Wu, et al.
Thrombosis Journal|February 5, 2024
Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysisShuangshuang Ma, Guohui Fan, Feiya Xu, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 1, 2022
Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment: Developed and Validated from 1,017 Medical and Surgical PatientsZhu Zhang, Yifan Wu, Qingxia Liu, et al.
Frontiers in Cardiovascular Medicine|August 22, 2022
Association between <i>CES1</i> rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysisHaobo Li, Zhu Zhang, Haoyi Weng, et al.
Pharmacological Reviews|March 27, 2026
International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applicationsAnthony P Davenport, Thomas L Williams, Duuamene Nyimanu, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Hypertension (Dallas, Tex. : 1979)|February 26, 2015
Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonistAimee L Brame, Janet J Maguire, Peiran Yang, et al.
Pageof 9